Ireland
--:--IST
Recruiting Not applicable

Efficacy and Acceptability of the Luna EMG Rehabilitation Robot on Motor Recovery of the Upper Limb in the Chronic Phase of Stroke

NCT05902910 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2023-06-12
Last updated
2026-06-10

Condition(s) studied

Stroke

Investigational drug(s) / intervention(s)

LUNA-EMG Robot

LUNA-EMG Robot: During phase B, patients will benefit from functional rehabilitation of their upper limbs and from 30mn of training assisted by the LUMA-EMG robot.

Study summary

Recent work on large cohorts of chronic stroke (\>6 months post-stroke) have shown that intensive training of the upper limb in the chronic stroke patients can lead to substantial motor and functional gains that are maintained at 6 months post intervention.

A very prolonged (12 weeks) and very intensive (5 hours daily) training applied to chronic patients after stroke brings a substantial gain both motor and functional which is maintained at 3 months post intervention.

Robotic rehabilitation have been shown to be as effective as any other treatment used in rehabilitation. But the methods of implementation remain widely debated. At that time, most robotic therapies have tried to reproduce functional movement mainly pointing objects.

We want to demonstrate that analytic movements of the elbow and the shoulder performed with the Luna-EMG robot can replace part of usual physiotherapy treatment with at least the same effectiveness on the recovery of fluid movements of the upper limb after a stroke.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age \>= 18 years * Hemiparesis after a first stroke with more than 1 year time interval * Functional upper limb: ability to do a pointing task at 90% of the hand-acromion distance (free trunk). * Spastic hypertonia of the elbow flexors 0-2/4 on the Modified Ashworth scale * Patient affiliated with social security * Patient having signed a consent to participate in the research Exclusion Criteria: * Inability to sign written consent * Flexed elbow \> 30° during passive mobilization of the upper limb * EVA\>3 in the upper limb at rest or during mobilization * Complete loss of upper limb proprioception * Neuro-orthopedic surgery of the upper limb for spasticity: neurotomy, tenotomy, transfer * Pregnant or breastfeeding woman

Primary outcome measure(s)

  • Fluidity of the upper limb — up to 7.5weeks
    Repeated evaluation of hand movement by the SPARC index during five pointing tasks at 90% of the length of the upper limb at clavicle height, at comfortable speed.

Trial sites (1)

FacilityCityRegionStatus
CHU Brest Brest France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05902910 on ClinicalTrials.gov ↗ ← All trials in France